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Gap junction channels (GJCs) and hemichannels (HCs) are composed of protein subunits
termed connexins (Cxs) and are permeable to ions and small molecules. In most organs,
GJCs communicate the cytoplasm of adjacent cells, while HCs communicate the intra
and extracellular compartments. In this way, both channel types coordinate physiological
responses of cell communities. Cx mutations explain several genetic diseases, including
about 50% of autosomal recessive non-syndromic hearing loss. However, the possible
involvement of Cxs in the etiology of acquired hearing loss remains virtually unknown.
Factors that induce post-lingual hearing loss are diverse, exposure to gentamicin an
aminoglycoside antibiotic, being the most common. Gentamicin has been proposed to
block GJCs, but its effect on HCs remains unknown. In this work, the effect of gentamicin
on the functional state of HCs was studied and its effect on GJCs was reevaluated in HeLa
cells stably transfected with Cxs.We focused on Cx26 because it is the main Cx expressed
in the cochlea of mammals where it participates in purinergic signaling pathways.We found
that gentamicin applied extracellularly reduces the activity of HCs, while dye transfer across
GJCs was not affected. HCs were also blocked by streptomycin, another aminoglycoside
antibiotic. Gentamicin also reduced the adenosine triphosphate release and the HC-
dependent oscillations of cytosolic free-Ca2+ signal. Moreover, gentamicin drastically
reduced the Cx26 HC-mediated membrane currents in Xenopus laevis oocytes.Therefore,
the extracellular gentamicin-induced inhibition of CxHCsmay adversely affect autocrine and
paracrine signaling, including the purinergic one, which might partially explain its ototoxic
effects.
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INTRODUCTION
Two cells in close contact can exchange metabolites, second mes-
sengers and ions through gap junction channels (GJCs; Goldberg
et al., 2004). Consequently, GJCs are key elements for diverse
coordinated physiological responses of cell communities in most
organs. Each GJC is made by the serial docking of two hemichan-
nels (HCs), each one contributed by one of two adjacent cells. In
turn, eachHC is composedof six protein subunits called connexins
(Cxs; Sáez et al., 2003). UndockedHCs are cellmembrane channels
permeable to ions and small molecules, constituting a commu-
nication pathway between the cytoplasm and the extracellular
environment (Sáez et al., 2005).
Several mutations in genes coding for Cxs cause congenital
prelingual syndromic and non-syndromic hearing loss. About
50% of the hearing loss cases are congenital, being most frequently
causedbymutations in theGJB2gene that encodesCx26 (Martínez
Abbreviations: CCCP, carbonyl cyanide 3-chlorophenylhydrazone; CPA, cyclopi-
azonic acid; Cxs, connexins; Etd, ethidium; GJCs, gap junction channels; HCs,
hemichannels.
et al., 2009). The remaining 50% of these cases is due to environ-
mental causes, including bacterial and viral infections, acoustic
trauma and ototoxic drugs (Resendes et al., 2001). However, it
remains unknown whether Cx26 HCs participate in the etiology
of acquired hearing loss.
According to the World Health Organization (WHO, 1994),
ototoxic drugs are substances of various structures and classes
that cause harmful effects in hearing and/or balance organs.
This group of molecules includes the aminoglycosides, which
are the most common and dangerous ototoxic drugs. Iso-
lated from Streptomyces or Micromonospora, they are highly
hydrophilic antibiotics and have two or more amino groups
that confer them a basic nature (Begg and Barclay, 1995).
Due to high efﬁcacy and low cost, aminoglycosides are widely
used in the treatment of infections caused by aerobic Gram-
negative bacteria as well as some mycobacteria (González and
Spencer, 1998). However, their use is limited due to nega-
tive side effects on kidney and cochlea (for recent reviews,
see López-Novoa et al., 2011; Xie et al., 2011). In the inner
ear, the ototoxicity induced by aminoglycosides culminates in
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the destruction of the cochlear sensory hair cells (Huth et al.,
2011).
The most extensively studied aminoglycoside is gentamicin.
Among the proposed mechanisms for its ototoxicity and nephro-
toxicity, it has been suggested the generation of reactive oxygen
species and nitric oxide (Sha and Schacht, 1998; Basnakian et al.,
2002; Hong et al., 2006; Choung et al., 2009). The routes of gen-
tamicin uptake in the inner ear structures are not fully understood,
but several mechanisms have been proposed, including mechan-
otransducer channels (METs) located on stereocilia of hair cells,
endocytosis in the apical or basolateral membranes of the organ
of Corti, TRP channels or adenosine triphosphate (ATP) receptors
(Huth et al., 2011). Moreover, it has been reported that MET chan-
nel opening is required to induce gentamicin toxicity in hair cells,
suggesting an intracellular toxicity mechanism (Alharazneh et al.,
2011). In addition, early studies suggested that cochleotoxicity
of gentamicin is an excitotoxic process involving the activation
of NMDA receptors (Basile et al., 1996), which might also be
explained by the generation of free radicals (Sha and Schacht,
1998). In contrast, aminoglycosides have been shown to block a
variety of ionic channels, such as hair cell METs (Jaramillo and
Hudspeth, 1993), acetylcholine receptors (Blanchet et al., 2000)
and purinergic ionotropic channels (Bongartz et al., 2010), all
of which might partially explain their toxic effects. Purinergic
signaling is one of the main mechanisms of paracrine signal-
ing in the cochlea and has been associated to activation of K+
recycling in cochlear supporting cells, being fundamental for
the normal functioning of this sensory organ (Zhu and Zhao,
2010).
More than a decade ago, Todt et al. (1999) demonstrated that
extracellular gentamicin inhibits gap junctional electrical coupling
through free radical production in isolated cochlear supporting
cells. However, the possible effects of gentamicin on HCs remain
unknown, and the mechanisms responsible for its effects on GJCs
are still not fully understood. In this work, we show that gen-
tamicin applied to the extracellular media reduces the functional
activity of HCs in a Cx composition-independent way. However,
the same gentamicin concentration has no effect on intercellular
dye coupling through GJCs. Gentamicin also reduces the oscil-
lations of Cx HC-dependent cytosolic Ca2+ signals elicited by
extracellular ATP in HeLa-Cx26 cells. Moreover, we found that
gentamicin, like other GJC/HC blockers, reduces ATP release in
HeLa-Cx26 cells, triggeredbydivalent cation-free solution (DCFS)
or by UTP, a purinergic receptor agonist. Since Cx HCs play a rel-
evant role as cellular membrane pathways for autocrine/paracrine
signaling including the purinergic signaling of the inner ear
(Zhao et al., 2005), gentamicin-induced Cx HC dysfunction may
adversely affect these pathways, partially explaining the ototoxicity
induced by this antibiotic through an extracellular mechanism.
MATERIALS AND METHODS
REAGENTS
Ethidium (Etd) bromide, LaCl3, adenosine triphosphate disodium
(Na2ATP),cyclopiazonic acid (CPA,sarcoplasmic reticulumCa2+-
pump inhibitor), carbonyl cyanide 3-chlorophenylhydrazone
(CCCP, H+ ionophore and uncoupler of oxidative phospho-
rylation in mitochondria), U73122 [Phospholipase C (PLC)
inhibitor], carbenoxolone (CBX) and streptomycin were obtained
from Sigma-Aldrich (St. Louis, MO, USA). Fura-2-AM was
obtained from Molecular Probes (Eugene, OR, USA) and gen-
tamicin sulfate from Invitrogen Life Technologies (Carlsbad, CA,
USA). Polyclonal anti-P2Y2, -P2Y4, and -P2Y6 receptor anti-
bodies, as well as goat anti-rabbit and anti-mouse secondary
antibodies conjugated to horseradish peroxidase, were obtained
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).
The mimetic peptide Gap26 (sequence: N-VCYDKSFPISHVR-
C) was synthesized by Beijing SBS Genetech Co. Ltd. (Beijing,
China).
GFP-TAGGED Cx26 CONSTRUCT IN pcDNA3.1
The rCx26-GFP fusion protein (rCx26-GFP) was generated as
described previously by Jara et al. (2012). The coding region
of rat Cx26 (rCx26, NM_001004099.1) was subcloned into
pcDNA3.1/CT-GFP-TOPO (Invitrogen Life Technologies, Carls-
bad, CA, USA), according to the manufacturer’s instructions. The
coding region of the construct was fully sequenced.
CELL CULTURE
HeLa-Parental cells were obtained from ATCC (CCL-2; ATCC,
Rockville, MD, USA) and were stably transfected with the
rCx26-GFP construct using Lipofectamine 2000 (Invitrogen Life
Technologies, Carlsbad, CA, USA), according to the man-
ufacturer’s instructions. HeLa cells stably expressing rCx26
(NM_001004099.1) were kindly provided by Dr. Bruce Nicholson
(Department of Biochemistry at the University of San Antonio,
San Antonio, TX, USA), while HeLa cells stably expressing mouse
Cx26 (mCx26, NM_008125.3), Cx43 (mCx43, NM_010288.3), or
Cx45 (mCx45, NM_001159383.1) were kindly provided by Dr.
Klaus Willecke from the LIMES Institute (Bonn Universität, Ger-
many). All cell lines were grown at 37◦C and 5% CO2 in DMEM
supplemented with 10% fetal bovine serum (GIBCO, Invitro-
gen), 100 U/ml penicillin, 100 μg/ml streptomycin sulfate, and
0.5 μg/ml puromycin to select transfected cells. HeLa rCx26-GFP
cells were selected with 500 μg/ml G418. All cell lines were used
48h after seeding, and all antibiotics used for selection andmainte-
nance were not included during this period of time. Untransfected
HeLa-Parental cells were used as control.
HC ACTIVITY
The HC activity was evaluated using the Etd uptake method as
described (Figueroa et al., 2013). In brief, sub-conﬂuent HeLa
cells grown on glass coverslips were washed twice with record-
ing solution [in mM: NaCl (148); KCl (5); CaCl2 (1.8); MgCl2
(1); glucose (5); HEPES (5), pH = 7.4] containing 5 μM Etd.
Basal ﬂuorescence intensity from the nucleus of each cell was
recorded for 5 min, using an Olympus BX 51W1I upright micro-
scope (Olympus America Inc., Center Valley, PA, USA). Next, cells
were washed three times with (Ca2+/Mg2+-free) DCFS and the
ﬂuorescence intensities of the nuclei were recorded. At the end
of each experiment, the Cx HC blocker La3+ was added to con-
ﬁrm HC mediated Etd uptake (Contreras et al., 2002; Retamal
et al., 2007). Dye uptake of each cell was digitally photographed
using a CCD monochrome camera (CFW-1310M; Scion; Fred-
erick, MD, USA). Images were captured every 30 s (exposure
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time = 30 ms, gain = 0.5). Metaﬂuor software (version 6.2R5,
Universal Imaging Co., Downingtown, PA, USA) was used for
data acquisition and off-line image analysis. The ﬂuorescence
intensity of at least 30 cells per experiment was averaged and
plotted against time (expressed in minutes). Lastly, the slope,
here called Etd uptake rate, was calculated using Microsoft
Excel software and expressed as arbitrary units per minutes
(AU/min).
hCx26 cRNA PREPARATION AND INJECTION INTO Xenopus laevis
OOCYTES
The plasmid pOocyte-Cx26, containing human Cx26 cDNA
(hCx26), was kindly provided by Dr. Guillermo Altenberg (Texas
TechUniversityHealth SciencesCenter, Lubbock,TX,USA). cRNA
coding for hCx26 was prepared as previously described (Figueroa
et al., 2013). To reduce expression of endogenous Cx38, an anti-
sense oligonucleotide directed against Cx38 was used. After the
injection of the cRNA, Oocytes were maintained in Barth’s solu-
tion [in mM: NaCl (88); KCl (1); CaCl2 (5); MgCl2 (0.8); HEPES
(10), pH = 7.4] supplemented with 0.1 mg/ml gentamicin and
20 units/ml of penicillin-streptomycin.
MEMBRANE CURRENT VIA HCs
Dual whole cell voltage clamp recordings of X. laevis oocytes
injected with hCx26 cRNA were carried out as described (Reta-
mal et al., 2011) using a two electrode voltage clamp ampliﬁer
for oocytes (Warner Instruments, model OC-725C) connected
to a digital-to analog converter (Molecular Devices, model Digi-
Data 1440A). ND96 medium [in mM: NaCl (96); KCl (2); CaCl2
(1.8); MgCl2 (1); HEPES (10), pH = 7.4] was used as bath solu-
tion in all experiments. Recording pipettes were ﬁlled with 3 M
KCl. For data acquisition and analysis, the pClamp 10 software
was used. Currents were measured after 15 s rectangular volt-
age pulses, ranging from −60 to +40 mV, in 10 mV steps with a
holding potential of −60 mV and 10 s intervals between pulses.
Female X. laevis were obtained from the animal facility of Univer-
sidad de Chile, and the Commission of Bioethics and Biosafety
of the Universidad del Desarrollo approved the experimental
protocols.
INTRACELLULAR Ca2+ SIGNAL
The intracellular Ca2+ signal was evaluated as described (Figueroa
et al., 2013). The intracellular Ca2+ signal was monitored in Fura-
2-AM (5 μM) loaded HeLa cells grown on glass coverslips, and
recording solution described above for dye uptake experiments
was used. Fluorescence from regions of interest (ROI’s) covering
single Fura-2 loaded cells was determined at excitation wave-
lengths of 340 and 380 nm, while ﬂuorescence emission was
collected at 510 nm every 3 s using an Olympus BX 51W1I
upright microscope. The intracellular Ca2+ signal was calculated
as R = F340 nm/F308 nm, and the background was subtracted. Ca2+
transients were evoked by extracellular application of ATP and
signals obtained were averaged, including at least 30 cells per
experiment. Subsequently, the area under curve (AUC) and dura-
tion (measured as the time between the ﬁrst increase in Ca2+
signal until the return to baseline) were calculated and represented
graphically.
EXTRACELLULAR ATP MEASUREMENT
Adenosine triphosphate release from HeLa-rCx26 cells was deter-
mined using the ATP bioluminescence assay kit (Sigma) in
combination with a spectroﬂuorometer (Jasco Corp., FP-63000,
Tokyo, Japan). HeLa-rCx26 cells were seeded into 60 mm cul-
ture plates 24 h before each experiment or until they reached
70% conﬂuence. For extracellular ATP measurements, the culture
medium was removed and cells were washed twice with DCFS
or Ca2+/Mg2+-containing solution. Then, cells were incubated
for 5 min in 500 μl of DCFS or treated with 100 μM UTP in
Ca2+/Mg2+-containing solution to induce ATP release. Subse-
quently, the 500μl of extracellular solutionwere carefully collected
to avoid damaging the cells, and ATP content was determined
immediately using the luciferin/luciferase bioluminescence assay.
To this end, 50 μl of the extracellular solution were mixed in the
cuvette with 50 μl of luciferin/luciferase reagent, and the average
light signal wasmeasured for 10 s with a spectroﬂuorometer (Jasco
Corp., FP-63000, Tokyo, Japan). The different reagents used in
these experiments were diluted in 500 μl of DCFS or Ca2+/Mg2+
solution resulting in the following concentrations: 200 μM gen-
tamicin and 100μMCBX.TheATP concentrationwas determined
by using a luminescence standard curve, and data were normalized
by the total cellular protein present in the plate. When CBX and
gentamicin were used, they were included from the ﬁrst wash at
the indicated concentration.
WESTERN BLOT ANALYSES
Relative levels of proteins were assayed by Western blot anal-
yses as described (Figueroa et al., 2013). Blots were incubated
with primary polyclonal anti-P2Y2, -P2Y4, or -P2Y6 antibodies
overnight at 4◦C, followed by ﬁve washes with TBS, 1% Tween-20
buffer. Then, they were incubated with goat anti-rabbit sec-
ondary antibodies and conjugated with horseradish peroxidase.
The immunoreactivity was detected by electrogenerated chemi-
luminescence (ECL) using the SuperSignal kit (Pierce, Rockford,
IL, USA) according to the manufacturer’s instructions. Blots were
also developed with α-tubulin, used as loading control.
DYE COUPLING
The functional state of GJCs was evaluated as described (Figueroa
et al., 2013). Brieﬂy, conﬂuent HeLa cell cultures grown on
coverslips were used in each experiment. Single cells were ion-
tophoretically microinjected with a glass micropipette ﬁlled with
75 mM Etd in water or Lucifer yellow (LY, 5% w/v in 150 mM
LiCl). Dye coupling index was calculated as the mean number of
cells to which the dye spread occurred. All microinjections were
performed in HCO−3 -free F-12 medium buffered with 10 mM
HEPES (pH 7.4) containing 200 μM La3+ to avoid cell leakage
of the microinjected dye via HCs. Fluorescent cells were observed
using a Nikon inverted microscope equipped with epiﬂuorescence
illumination (Xenon arc lamp) and Nikon B ﬁlter to LY (excita-
tion wavelength 450–490 nm; emission wavelength above 520 nm)
and XF34 ﬁlter to Etd ﬂuorescence (Omega Optical, Inc., Brattle-
boro, VT, USA). Photomicrographs were obtained using a CCD
monochrome camera (CFW-1310M; Scion; Frederick, MD,USA).
In all experiments, dye couplingwas testedby injecting aminimum
of 14 cells.
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STATISTICS
Statistical analysis was performed using GraphPad Prism 5 soft-
ware for Windows (GraphPad Software, San Diego, CA, USA).
Data sets (means ± SEM) were compared using one-way analysis
of variance (ANOVA) followed by a Tukey’s post-test or Student’s
t-test for pair-wise comparisons.
RESULTS
GENTAMICIN INHIBITS HC ACTIVITY ELICITED BY EXTRACELLULAR
DIVALENT CATION-FREE SOLUTION
The functional state of HCs was determined by measuring the
cellular uptake of Etd. At a concentration of 5 μM, Etd diffuses
across the cell membrane preferentially via HCs (Schalper et al.,
2008). Once in the intracellular space, it binds to nucleic acids
and emits ﬂuorescence that is proportional to the HCs activ-
ity (Contreras et al., 2002; Schalper et al., 2008; Orellana et al.,
2010). Etd uptake was measured during 5 min in HeLa-Parental
and HeLa-rCx26 cells exposed to a saline solution with physi-
ologic extracellular divalent cation concentrations (Figure 1A,
Ca2+/Mg2+). In HeLa-rCx26 cells, the ﬂuorescence intensity
was slightly higher than in HeLa-Parental cells (Figure 1B,
Ca2+/Mg2+), which do not express Cx26 HCs. In order to
increase the open probability of rCx26 HCs, cells were bathed
in DCFS (Jara et al., 2012). A rapid increase in ﬂuorescence inten-
sity was measured in HeLa-rCx26 but not in HeLa-Parental cells
(Figures 1A,B, DCFS). Lastly, the application of 200 μM gen-
tamicin to the bath solution reduced the DCFS-induced Etd
uptake in HeLa-rCx26 cells to values similar to those recorded
in the presence of physiologic extracellular Ca2+/Mg2+ con-
centrations either in HeLa-rCx26 or -Parental cells (Figure 1B,
gentamicin).
The basal Etd uptake rate of HeLa-rCx26 cells bathed with
saline solution containing divalent cations was slightly higher than
that of HeLa-Parental cells (m1 = 0.06AU/min forHeLa-rCx26 v/s
m1 = 0.04 AU/min for HeLa-Parental; Figure 1B Ca2+/Mg2+ ﬁrst
5 min and C), which might result from basal activity of rCx26
HCs. However, the Etd uptake and Etd uptake rate of HeLa-
rCx26 cells was ∼two fold higher when bathed with DCFS than
in the presence of extracellular divalent cations (Figures 1B,C;
m1 = 0.06 AU/min v/s m2 = 0.13 AU/min), whereas the Etd
uptake rate of HeLa-Parental cells in DCFS remained indistin-
guishable from the rate measured in the presence of physiological
FIGURE 1 | Gentamicin blocks the ethidium uptake induced by a
divalent cation-free solution (DCFS) in HeLa-Cx26 cells. The ethidium
(Etd) uptake was evaluated in HeLa-Parental or -Cx26 cells bathed
with divalent cation (Ca2+/Mg2+) or DCFS solution in time-lapse
measurement experiments. (A) Representative ﬂuorescent ﬁelds
showing Etd ﬂorescence of HeLa-Parental or -rCx26 cells incubated
in saline solution containing 5 μM Etd, under control conditions
(Ca2+/Mg2+, 5 min), after exposure to DCFS (10 min) or after 5 min
exposure to DCFS containing 200 μM gentamicin. Scale bar, 40 μm.
(B) Representative time-lapse experiments showing Etd uptake in
HeLa-Cx26 and -Parental cells under control conditions (Ca2+/Mg2+,
ﬁrst 5 min), after exposure to DCFS solution followed by the
application of 200 μM gentamicin (last 5 min). m1, m2, m3 = average
slope. Measurements were taken every 30 s as ﬂuorescence emission
intensity of Etd bound to DNA and referred as ﬂuorescence intensity
expressed in arbitrary units (AUs). Each value corresponds to the
mean ± SEM of at least 30 cells. (C) Etd uptake rate of Hela-Parental
or -rCx26 cells measured under control conditions and after exposure
to DCFS with or without 200 μM La3+ or 200 μM gentamicin. Data
are presented as means ± SEM, the digit within each bar corresponds
to the number of independent experiments under that condition.
***P < 0.001.
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concentrations of divalent cations (Figures 1B,C, Ca2+/Mg2+
v/s DCFS). Then, the Etd uptake was drastically inhibited by
200 μM gentamicin (Figure 1B) and the Etd uptake rate val-
ues changed from m2 = 0.13 AU/min to m3 = 0.05 AU/min
in Hela-rCx26 cells, but was not affected in HeLa-Parental
cells (Figure 1C, DCFS + gentamicin). Similar results were
obtained in HeLa-rCx26 cells bathed with DCFS and treated
with 200 μM La3+ (Figure 1C), a widely used Cx HC blocker
(Sáez et al., 2003). The gentamicin-induced Etd uptake rate inhi-
bition in Hela-rCx26 cells was found to be reversible because
it was restored by replacing the bath solution with gentamicin-
free DCFS (Figures 2A,B). The gentamicin-induced inhibition
of rCx26 HCs occurred in a concentration-dependent man-
ner, being 133.4 ± 1.1 μM the concentration that induced
50% Etd uptake rate inhibition (IC50; Figure 2C). Gentamicin
also inhibited Etd uptake in HeLa-rCx26GFP cells as well as
in mCx26, mCx43, or mCx45 bathed in DCFS (Figure 2D).
In addition, streptomycin (Strep 200 μM), another aminogly-
coside antibiotic, also inhibited the Etd uptake of HeLa-rCx26
(Figures 2E,F), -mCx43 and -mCx45 cells in DCFS (Figure 2F).
In HeLa-mCx45 cells, Etd uptake was reduced to values below
the ones recorded under control condition (Figure 2F), suggest-
ing that these HCs present a higher open probability under basal
condition.
GENTAMICIN INHIBITS THE CELL MEMBRANE CURRENT MEDIATED BY
Cx26 HCs
To test whether gentamicin inhibits Cx26 HCs, we recorded
membrane currents generated by the application of rectangu-
lar command voltages under whole cell dual voltage clamp in
X. laevis oocytes expressing hCx26. Endogenous oocyte Cx38
expression was inhibited by using speciﬁc antisense. Forty eight
hours after the cRNA injection, oocytes were depolarized from
−60 to +40 mV (10 mV steps) for 15 s (Figure 3A). Under
control conditions (ND96 solution containing 1.8 mM Ca2+), the
activation of an outward current was evident (at voltages above
0 mV) followed by a tail current upon repolarization to −60 mV
(Figure 3A). These currents were virtually absent in oocytes
injected with Cx38 antisense oligonucleotide (Figure 3B), indi-
cating this was mediated by activated hCx26 HCs. Then, cells were
FIGURE 2 | Gentamicin blocks connexin26 hemichannels in a reversible-
and concentration-dependent manner and also blocks connexin43 and
connexin45 hemichanels. (A) Representative time-lapse experiment
showing ethidium (Etd) uptake in cells transfected with rat connexin26
(HeLa-rCx26 cells) under control conditions (Ca2+/Mg2+), after exposure to
DCFS, followed by 5 min exposure to DCFS containing 200 μM gentamicin
and washout of gentamicin with DCFS (last 10 min), m1, m2, m3,
m4 = average slope. (B) Average Etd uptake rate (experiments as shown
inA); data were normalized to the control Etd uptake level (dotted line).
(C) Concentration-response curve showing the inhibition of DCFS-induced
Etd uptake prompted by different gentamicin concentrations in HeLa-rCx26
cells. Each point represents the mean ± SEM (n = 3). Values were normalized
to the maximal response in the absence of gentamicin and were included in
the Hill equation, IC50 = 133.4 ± 1.1 μM, R2 = 0.95. (D) Etd uptake rates of
HeLa cells expressing rat Cx26 (rCx26), mouse Cx26 (mCx26), rat Cx26-GFP
(rCx26-GFP), mouse Cx43 (mCx43) or mouse Cx45 (mCx45), after exposure
to DCFS followed by 5 min exposure to DCFS containing 200 μM gentamicin.
Data were normalized to the Etd uptake value measured under control
conditions (Ca2+/Mg2+ solution, dotted line) and are presented as
mean ± SEM (n = 3). (E) Representative time-lapse curve showing Etd
uptake in HeLa-rCx26 cells in control conditions and after exposure to
DCFS followed by 200 μM streptomycin, m1, m2, m3 = average slope.
(F) DCFS-induced Etd uptake normalized to control uptake in absence (gray
bar) or presence (white bar) of 200 μM streptomycin of HeLa cells expressing
rCx26, mCx43, or mCx45. Values recorded in at least 30 cells per experiment
were included (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.
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FIGURE 3 | Gentamicin inhibits the membrane current mediated by
human connexin hemichannels.The membrane current of Xenopus
laevis oocytes injected with connexin38 antisense oligonucleotide and
human connexin (Cx26) cRNA was evaluated in whole cell modality using
two electrodes. (A) Currents induced by depolarization from −60 to
+40 mV (10 mV steps, for 15 s) under control condition (upper panel) or in
the presence of 300 or 600 μM gentamicin (middle panel) and 300 μM
gentamicin plus 200 μM La3+ (lower panel). (B) Currents induced by
depolarization from −60 to +40 mV in oocytes non-injected with Cx26
cRNA under control conditions (upper panel) or in the presence of 300 or
600 μM gentamicin (middle panel) and 300 μM gentamicin plus 200 μM
La3+ (lower panel). (C) Average maximal tail currents from 5 oocytes in the
presence or absence of 300 or 600 μM gentamicin and 300 μM gentamicin
plus 200 μM La3+. ***P < 0.005 and n.s: not signiﬁcant.
treated for 3–5 min with 300 μM gentamicin applied in the bath,
and both the maximal and tail currents were drastically reduced
(Figure 3A, middle) and completely abolished by the subsequent
addition of La3+ (Figure 3A, bottom). To minimize contamina-
tion with endogenous currents, we measured the maximal current
at −60 mV before the depolarization at +40 mV. It was observed
that gentamicin-induced a concentration-dependent decrease of
maximal tail current (Figure 3C). Under control conditions, the
maximal tail current recorded was 0.34 ± 0.03 μA, and after
the addition of 300 or 600 μM gentamicin it was 0.07 ± 0.02
and 0.03 ± 0.02 μA, respectively (Figure 3C). Similar results
were obtained in presence of 200 μM La3+ in the extracellu-
lar solution (Figure 3C). In the absence of extracellular Ca2+,
outward currents generated with the different command volt-
ages were more prominent than those recorded in bath solution
containing 1.8 mM Ca2+ (Figure 4A). In the absence of extracel-
lular Ca2+, 300 μM gentamicin inhibited the membrane currents
(Figure 4A) by ∼70% (from 4.15 ± 0.87 to 1.28 ± 0.32 μA;
Figure 4B).
FIGURE 4 | Gentamicin inhibits the membrane current mediated by
human connexin26 hemichannels in nominal Ca2+-free solution.The
membrane current of Xenopus laevis oocytes injected with connexin38
antisense oligonucleotide and human connexin26 cRNA was evaluated in
whole cell modality using two electrodes in ND96 without Ca2+ and
Mg2+. (A) Currents induced by depolarization from −60 to +40 mV (10 mV
steps, for 15 s) under control conditions (upper panel) or in the presence of
300 μM gentamicin (lower panel). (B) Average maximal currents at +40 mV
from 5 oocytes in the presence or absence of 300 μM gentamicin.
*P < 0.01.
GENTAMICIN REDUCES THE ATP-INDUCED Ca2+ SIGNAL IN
HeLa-rCx26 CELLS
Since HCs have been suggested to play a major role in inner ear
purinergic signaling (Zhao et al., 2005) and because inhibition
of Cx43 HCs reduces the intracellular Ca2+ signals elicited by
bradykinin (De Bock et al., 2012), we tested whether gentamicin
affects the ATP-induced Ca2+ signals in HeLa-rCx26 cells.
Gentamicin was applied to the bath solution 5 min prior to
stimulationwith extracellularATP in presence of 1.8mM[Ca2+]0.
Fura-2 loaded HeLa-rCx26-GFP cells were used to facilitate iden-
tiﬁcation of cells expressing Cx26 and 10 μM ATP was applied
in all experiments. Figure 5 shows a representative experiment
including ﬁve representative cells in each record. In all cells, the
application of 10 μM ATP induced a fast initial increase in Ca2+
signal. In HeLa-Parental cells, small oscillations with ∼5 s inter-
vals were superimposed with a sustained Ca2+ signal increase
that decayed progressively over time (Figure 5A). In contrast, in
Hela-rCx26-GFP cells the oscillations were more evident than in
parental cells (Figure 5C). TheATP induced-Ca2+ signal increases
were slightly reduce by 200 μM gentamicin in HeLa-Parental
cells (Figure 5B). However, gentamicin signiﬁcantly reduced the
ATP-induced Ca2+ signals in HeLa-rCx26-GFP cells (Figure 5D).
Therefore, the most frequent effect of gentamicin was a reduction
in oscillation frequency (e.g., in HeLa-rCx26-GFP), thus, from
the ﬁrst Ca2+ rise to the return to baseline, cells oscillated an
average of 8.8 ± 0.4 times in control conditions and were reduced
to 5.1 ± 0.4 by 200 μM gentamicin (100 cells randomly analyzed
in seven independent experiments). The AUC and duration of the
ATP-elicitedCa2+ signalswere signiﬁcantly reducedby gentamicin
in HeLa rCx26-GFP, but the reductions observed in HeLa-Parental
cells were not statistically signiﬁcant (Figures 5E,F). We also
measured the Ca2+ signal after 20 min incubation with gen-
tamicin, and no signiﬁcant differences with respect to the values
recorded after 5 min treatment were found (data not shown).
Similar results were obtained in HeLa rCx26-GFP after 10 min
preincubation with 100 μM CBX, a HC/GJC blocker, or 20 min
preincubation with 200 μM GAP-26 (Figures 5E,F), a mimetic
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FIGURE 5 | Gentamicin and hemichannel blockers reduce theATP-evoked
Ca2+ signal in HeLa-rCx26GFP cells. HeLa-Parental cells or HeLa cells
stably transfected with rCx26-GFP were loaded with Fura-2 and then
stimulated with bath application of 10 μM ATP. (A)Time course of ATP-evoked
intracellular Ca2+ signal under control conditions in HeLa-Parental cells. (B)
Time course of ATP-evoked intracellular Ca2+ signal in HeLa-Parental cells
pre-incubated for 5 min with 200 μM gentamicin. Five representative cells
are shown in each case. (C)Time course of ATP-evoked intracellular Ca2+
signal under control conditions in HeLa-rC26-GFP cells. (D)Time course of
ATP-evoked intracellular Ca2+ signal in HeLa-rC26-GFP cells pre-incubated for
5 min with 200 μM gentamicin. (E) Compiled data showing the amplitude of
Ca2+ signal changes evoked by extracellular ATP (mean ± SEM) in HeLa
parental and HeLa-rCx26GFP, measured as area under curve expressed as AU
in control conditions or after 5 min preincubation with 200 μM gentamicin,
10 min with 100 μM carbenoxolone (CBX) or 20 min with 200 μM GAP-26.
(F) Duration (time), from the ﬁrst Ca2+ signal increase until the return to
baseline (mean ± SEM) in HeLa-Parental and HeLa-rCx26GFP in control
conditions or after 5 min preincubation with 200 μM gentamicin, 10 min
with 100 μM CBX or 20 min with 200 μM GAP-26. For calculations of the
average traces (as shown in A) 40 cells per experiment were included. The
number of independent experiments is indicated in each bar. **P < 0.01,
***P < 0.001.
peptide that blocks Cx26 HCs (Evans and Leybaert, 2007). How-
ever, these blockers did not have signiﬁcant effect on parental cells
(Figures 5E,F).
It is known that extracellular ATP activates P2Y receptors cou-
pled to G proteins, which in turn can activate PLC-dependent
pathways, generating IP3 and thus promoting Ca2+ mobiliza-
tion from the sarcoplasmic reticulum (Abbracchio et al., 2006).
To determine whether this intracellular pathway is involved in the
ATP-induced Ca2+ signal oscillations in HeLa-rCx26, we used a
pharmacological approach. The possible involvement of PLC was
tested using U73122 as inhibitor since, as mentioned above; PLC is
a central component of the signal transductionmediated by activa-
tion of metabotropic purinergic receptors. To evaluate the partic-
ipation of the endoplasmic reticulum in the ATP-induced Ca2+
signal oscillations, we used CPA, a sarcoplasmic-endoplasmic
reticulum Ca2+-ATPase pump inhibitor (Suzuki et al., 1992). We
determined the possible involvement of mitochondria in the ATP-
induced Ca2+ signal oscillations (Ishii et al., 2006) in HeLa-rCx26
using the protonophore CCCP, which inhibits the mitochondrial
Ca2+ transport by collapsing the proton electrochemical gradient
(Bygrave, 1978).
To identify an optimal concentration at which the inhibitory
effect was reproducible, the effect of different concentrations of
each blocker was tested in Fura-2 loaded HeLa rCx26-GFP cells.
Figure 6 shows concentration-response experiments in which
each blocker exhibited a concentration-dependent inhibition of
ATP-induced Ca2+ signals. Neither U73122 nor CCCP elimi-
nated completely the Ca2+ signals, but they strongly reduced
them (Figures 6A,C,D). However, 10 μM CPA inhibited com-
pletely the ATP-induced Ca2+ signals (Figures 6B,D). These data
indicate that extracellular ATP is acting through metabotropic
receptors, activating PLC and releasing Ca2+ from the reticu-
lum. To conﬁrm these results, we tested whether HeLa cells
express metabotropic purinergic receptors. Western blot anal-
yses for P2Y receptors contained in whole HeLa-Parental and
HeLa-Cx26 cell lysates were performed. We used polyclonal anti-
bodies against different types of P2Y receptors (P2Y2R,P2Y4R,and
P2Y6R) previously reported in HeLa cells (Okuda et al., 2003).
Immunoreactive bands of ∼34 and 95 kDa were detected for
the three receptors in Hela-Parental cells and HeLa cells express-
ing rCx26 and rCx26-GFP, respectively (Figure 7). These bands
were also detected in mouse brain (MB) lysate used as posi-
tive control. P2YRs receptors have been described to be 308–379
amino acid proteins with mass ranging from 41 to 53 kDa
after glycosylation (D’Ambrosi et al., 2006). Bands with fast elec-
trophoretic mobility were near the predicted molecular mass of
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FIGURE 6 | Concentration-dependent effects of phospholipase C and
intracellular Ca2+ stores inhibitors on the ATP-induced Ca2+ signal.
The effect of different concentrations of (A) U73122, a phospholipase C
(PLC) inhibitor, (B) CPA, an endoplasmic reticulum Ca2+-ATPase pump
inhibitor and (C) CCCP, a protonophore, was tested on the Ca2+ signal
induced by 10 μM ATP. Representative average traces (including 40
cells per trace) measured in Fura-2 loaded HeLa-rCx26-GFP cells are
shown. Cells were preincubated with each blocker during 10 min prior
to stimulation with ATP. (D) Compiled data showing the amplitude of
the ATP-evoked Ca2+ signals (mean ± SEM) measured as area
under the curve and expressed as AU (mean ± SEM). Each trace
represents the average from 40 cells per experiment. The number of
independent experiments is indicated within each bar. *P < 0.05,
***P < 0.001.
P2Y2, P2Y4, and P2Y6 receptor protein subunits deduced from
their cDNA sequence, being 42, 41 and 36 kDa, respectively
(P41231, P51582, Q15077; SwissProtKB). These bands corre-
spond to the monomeric forms while higher-order bands between
72 and 95 kDa may correspond to post-translational modiﬁed
forms due to glycosylation (Sage and Marcus, 2002; Delbro et al.,
2005), oligomeric forms of each receptor (D’Ambrosi et al., 2006,
2007) or heterodimerization between purinergic receptor sub-
types (Yoshioka et al., 2001; Nakata et al., 2005; Suzuki et al.,
2006). Notably, HeLa cells transfected with rCx26 or rCx26-
GFP contained higher levels of the monomeric bands of each
receptor protein than HeLa-Parental cells did (Figures 7A,B,
43 kDa). The functional expression of each receptor identiﬁed
was also conﬁrmed using a pharmacological approach with dif-
ferent purinergic agonists such as ATP, UTP, and UDP (data not
shown).
GENTAMICIN REDUCES ATP RELEASE TRIGGERED BY ACTIVATION OF
P2Y RECEPTORS IN HeLa-rCx26 CELLS
Previous reports have shown that the expression of Cxs allows
HeLa cells to release ATP in response to DCFS or purinergic
receptor activation by UTP (Cotrina et al., 1998; De Vuyst et al.,
2007). We studied the changes in extracelullar ATP using the
luciferin-luciferase assay in response to DCFS to increase the open
probability of rCx26 HCs in HeLa cells. In DCFS the amount of
extracellular ATP was about 10-fold greater with respect to control
conditions (Ca2+/Mg2+,Figure 8A). Additionally, the application
FIGURE 7 | Detection of P2Y2, P2Y4, and P2Y6 receptors in
HeLa-Parental and HeLa-Cx26 cells.Total homogenates of HeLa-Parental
and HeLa cells expressing rCx26 or rCx26-GFP were resolved in sodium
dodecyl sulfate polyacrylamide gel electrophoresis (12% SDS-PAGE).
Membranes were probed with (A) anti-P2Y2R and anti-P2Y4R polyclonal or
(B) anti-P2Y6R antibodies. Protein loading was controlled with anti-α-tubulin
monoclonal antibody. Bands were detected with secondary anti-rabbit or
anti-mouse antiserum coupled to horseradish peroxidase by
electrogenerated chemiluminescence (ECL). MB, mouse brain (tissue
lysate); Lane 1, HeLa-Parental; Lane 2, HeLa-rCx26; Lane 3,
HeLa-rCx26-GFP.
of 200μMgentamicin or 100μMCBXreduced theDCFS-induced
ATP release to values similar to those recorded in the presence of
physiologic extracellular Ca2+/Mg2+ concentrations (Figure 8A).
We alsomeasured the release of ATPmediated by activation of P2Y
purinergic receptors by extracellular 100 μM UTP in HeLa rCx26
in the presence of extracelullar 1.8mMCa2+ and1mMMg2+. The
ATP concentration increased about seven fold compared to basal
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FIGURE 8 | Gentamicin reduces the ATP release induced by DCFS or
UTP in HeLa-rCx26 cells. ATP release from HeLa-rCx26 cells in response
DCFS and purinergic receptor stimulation by UTP. ATP released to the
extracellular solution was determined with an ATP bioluminescence assay
kit 5 min after stimulation. (A) ATP released by HeLa-rCx26 cells exposed
to DCFS, DCFS + 200 μM gentamicin (DCFS + Gen), DCFS + 200 μM
CBX (DCFS + CBX) or with Ca2+/Mg2+ containing solution (control).
(B) ATP released by HeLa-rCx26 stimulated with 100 μM UTP, 100 μM UTP
+ 200 μM gentamicin (UTP + Gen), 100 μM UTP +100 μM CBX (UTP +
CBX) in Ca2+/Mg2+ solution (control). The data are shown as means
[ATP] ± SEM of three independent experiments. ***P < 0.001.
release (without UTP, Figure 8B). Additionally the UTP-induced
ATP release was drastically reduced by 200 μM gentamicin or
100 μM CBX (Figure 8B). These results suggest that gentamicin
inﬂuences the amplitude, duration and shape of the ATP-induced
Ca2+ signal, probably by decreasing the release of ATP through
Cx HCs.
GENTAMICIN DOES NOT INHIBIT INTERCELLULAR GAP JUNCTIONAL
COMMUNICATION IN HeLa-rCx26 CELLS
We studiedwhether gentamicin inhibits GJCs inHeLa-rCx26 cells.
To this end, dye coupling experiments were performed in con-
ﬂuent cultures. Single cells were microinjected with a solution
containing Etd or LY, and the dye coupling index was scored in
absence and presence of 200 μM gentamicin in the extracellular
solution (Figures 9A and 8B). Under control conditions, a mean
of 10 ± 1 cells was scored. After 35 min exposure to 200 μM gen-
tamicin, the dye coupling index tended to increase (12 ± 1 Etd
coupled cells), although this response was not statistically signif-
icant compared to that of the control value (14 injected cells per
experiment, in three independent cultures). Similar results were
obtained using LY (from 8 ± 1 cells increased to 9 ± 1 cells after
treatment with gentamicin; Figures 9A,B). In HeLa cells trans-
fected with mCx43 the Etd coupling was not signiﬁcantly affected
by gentamicin applied in the extracellular solution (6 ± 1 cells
under control conditions and 7 ± 1 cells after treatment with
gentamicin; Figure 9B). When gentamicin was included in the
pipette to a ﬁnal concentration of 200 uM with the Etd solu-
tion, no signiﬁcant differences were observed in the number of
coupled cells in cultures of rCx26 or mCx43 (Figure 9B), indi-
cating that gentamicin not affect the dye coupling when applied
intracellularly.
DISCUSSION
In this work, we found that the aminoglycoside antibiotic gen-
tamicin applied extracellularly is a reversible Cx26 HC blocker
that does not affect the functional state of gap junctions. More-
over, gentamicin drastically reduced both, the intracellular Ca2+
increase and the release of ATP induced by P2Y receptor activation
by DCFS or UTP. Thus, the cellular toxicity of gentamicin might
be explained partially by a perturbation of the autocrine/paracrine
HC-dependent cell signaling, as in that mediated by extracellu-
lar ATP.
The addition of GFP to the C-terminus of rCx26 did not inter-
fere with the HC blocking effect of gentamicin, suggesting that the
C-terminal domain is not involved in gentamicin-induced inhibi-
tion of HCs. In addition, gentamicin also inhibited HCs formed
by mCx43 or mCx45, which have longer C-terminus, indicating
that its action is independent of the HC composition and the
length of the C-terminus, a characteristic reported previously for
other HC/GJC blockers (D’hondt et al., 2009; Wright et al., 2009).
Our results differ from a previous study where rCx26 was shown
not to form voltage-gated HCs in Xenopus oocytes and Neuro2A
cells (González et al., 2006). The apparent discrepancy may be
explained by differences in experimental procedures. González
et al. (2006) used extracellular solution containing 1.8 mM Ca2+
and 0.8mMMg2+. In contrast, we usedDCFS,which increases the
open probability of all Cx HCs so far studied (Sáez et al., 2003). In
agreement with our ﬁndings, activation of rCx26 HCs expressed
in HeLa cells has been previously induced by DCFS (Jara et al.,
2012).
Aminoglycosides block several ionic channels including hair
cell METs (Jaramillo and Hudspeth, 1993), ACh receptors
(Blanchet et al., 2000; Amici et al., 2005) and purinergic ionotropic
channels (Bongartz et al., 2010). In most of these channels, gen-
tamicin acts as open channel blocker (Kroese et al., 1989; Bongartz
et al., 2010). Here, gentamicinwas shown to inhibit Cx26HCopen
either by DCFS or depolarization of the cellular membrane. Both
conditions are known to increase the open probability of Cx26
HCs (Sánchez et al., 2010; Jara et al., 2012), and under these condi-
tions we observed the most potent inhibitory effect of gentamicin.
Thus, our data suggest that gentamicin could also act as open HC
blocker.
In organotypic mouse cochlea, long distance propagation of
intercellular calcium waves occurred through ATP released via
Cx30 and Cx26 HCs, whereas GJCs composed by the same
Cxs allow the simultaneous diffusion of IP3 across coupled cells
(Anselmi et al., 2008). Moreover, ATP released through HCs
located in cochlear supporting cells modulates the electromotility
of the outer hair cells by activation of its ionotropic purinergic
receptors that determine the cochlear sensitivity to sound stim-
ulation in mammals (Zhao et al., 2005). Thus, altered purinergic
signaling due to the blockade of HCs could have important con-
sequences in auditory processing since purinergic transduction
controls important aspects of the inner ear physiology, includ-
ing the cochlear ﬂuids homeostasis, essential for hearing (Housley
and Gale, 2010). Relevant to this paracrine signaling, we found
that gentamicin reduces the ATP-induced Ca2+ signal in HeLa-
rCx26, which is in agreement with a previous report in which
the ATP-induced Ca2+ transients of both HeLa-Cx26 and -Cx43
cells were inhibited by GAP26 and 18-βGA, two GJC/HC blockers.
However, these compounds did not signiﬁcantly affect the ATP-
induced Ca2+ signal in HeLa-Parental cells (Verma et al., 2009).
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FIGURE 9 | Gentamicin does not inhibit the intercellular transfer of
ethidium or Lucifer yellow between HeLa-rCx26 –mCx43 cells. Gap
junctional communication, expressed as dye coupling index, was evaluated in
conﬂuent cultures of HeLa-rCx26 or –mCx43 cells. A single cell was
microinjected with ethidium (75 mM Etd in water) or Lucifer yellow (5%
LY w/v in 150 mM LiCl) and the number of cells to which Etd or LY was
transferred in 2 min was scored. Gentamicin was applied extracellularly
or was included in the pipette at a ﬁnal concentration of 200 μM.
(A) Photomicrographs showing a ﬂuorescent ﬁeld of HeLa-xCx26 cells
microinjected with Etd or LY and transfer to adjacent cells under control
conditions and in the presence of 200 μM gentamicin applied extracellularly
5 min before the assay. Scale bar, 20 μm. (B) Quantitative analysis of dye
coupling between HeLa-rCx26 and HeLa-mCx43 cells under control
conditions (control) or treated with 200 μM gentamicin in the extracellular
solution or in the pipette, as indicated. Bar graphs summarize the results of
three independent experiments for each condition (the number of
microinjections is indicated within each bar). Values correspond to the
mean ± SEM of ﬂuorescent cells.
Our results demonstrate that activation of purinergic receptors
by UTP increases the release of ATP in HeLa-rCx26 cells, which
was inhibited by gentamicin and CBX. This is consistent with
previous reports showing that the expression of Cxs allows HeLa
cells to release ATP through HCs, as well as to mediate inter-
cellular transfer of second messengers, such as IP3, and thereby
generate larger Ca2+ waves (Cotrina et al., 1998; Paemeleire et al.,
2000; Beltramello et al., 2005). Therefore, gentamicin could alter
the purinergic signaling by blocking Cx26 HCs and consequently
would reduce the ATP release. However, the Cx26 HC permeabil-
ity to Ca2+ (Sánchez et al., 2010; Fiori et al., 2012) might also be
involved in the ATP-induced Ca2+ signal.
HeLa cells have been shown to express low levels of func-
tional P2X7Rs, which can be upregulated by pro-inﬂammatory
cytokines, such as IFNγ (Welter-Stahl et al., 2009). However,
and in agreement with Verma et al. (2009), our results in con-
trol conditions indicate that metabotropic purinergic receptors
are the main mediators of the ATP-evoked Ca2+ signal in HeLa
rCx26-GFP because they are strongly reduced by PLC inhibition
and completely abrogated by sarcoplasmic-endoplasmic reticulum
Ca2+-ATPase inhibition. Accordingly, it has been shown thatATP-
evoked Ca2+ signals in HeLa cells are mediated by metabotropic
receptors and are not signiﬁcantly different from those exhibited
by HeLa cells pre-treated with oATP, a P2X7R antagonist (Okuda
et al., 2003; Welter-Stahl et al., 2009). In spite of the fact that gen-
tamicin could block P2X2Rs (Bongartz et al., 2010), the previously
mentioned results rule out the possibility that gentamicin affects
the ATP-evoked signals by blocking ionotropic purinergic recep-
tors. In support of this interpretation, a previous study has shown
thatP2X2R is not expressed inHeLa cells (Welter-Stahl et al.,2009).
On the other hand, intercellular Ca2+ signals elicited through
photo stimulation of caged IP3 propagate normally in cochlear
organotypic cultures that lack P2X7Rs but fail to propagate in cul-
tures with defective expression of Cx26 or Cx30 (Anselmi et al.,
2008). Recently, Hu et al. (2012) reported that the expression
of Cx26 increases in the cochlear lateral wall of rats 3 h after
gentamicin administration, which could compensate for the loss
of HC activity. It remains unknown how the overexpression of
this protein is related to acquired hearing loss. In this line, we
found that expression of Cx26 or Cx26-GFP enhanced the lev-
els of the monomeric receptor. Changes in P2Y1R and P2Y4R
levels in response to deletion of Cx43 in astrocytes have been
described, and these changes in P2YRs also change the mode of
propagation of intercellular Ca2+ signals (Suadicani et al., 2003).
Moreover, other authors have suggested that Cx43 could inter-
act directly with some purinergic receptors, including the P2Y1R
(Iacobas et al., 2007). In light of the ﬁndings described above, we
hypothesize that changes in the distribution of monomeric forms
of purinergic receptors in response to Cx26 expression observed
in the experiments described herein are due to direct interaction
betweenCx26orCx26-GFPwith endogenously expressedpuriner-
gic receptors. However, future experiments are needed to address
this issue. Our ﬁndings are relevant in the purinergic signaling
context, because there is a growing amount of evidence showing
that ATP released through HCs can trigger intercellular signal-
ing, directly activating metabotropic and ionotropic purinergic
receptors of cells in close contact, regulating both physiological
and pathological processes in most tissues (Baroja-Mazo et al.,
2013).
Finally, we found that gentamicin does not inhibit dye cou-
pling via rCx26 or mCx43 GJCs when applied extracellularly.
These results differ from those published by Todt et al. (1999) that
showed inhibition of electrical gap junctional coupling induced
by gentamicin in Hensen cells. Additionally, the inhibitory effect
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is time-dependent and the major effect was observed after 20 min
treatment with gentamicin (Todt et al., 1999). In our experi-
ments, cells were preincubated with gentamicin for only 5 min,
and dye coupling was assessed during the following 30 min but
no signiﬁcant changes were observed. Relevant to this ﬁnd-
ing, it has been reported that some subtypes of HeLa cells
are resistant to oxidative stress and grow at high oxygen con-
centrations due to potent antioxidant mechanisms (Campian
et al., 2004). This feature might explain why we did not observe
gentamicin-induced reduction in dye coupling as that observed
in Hensen cells through an indirect mechanism involving pro-
duction of free radicals and suppression by catalase (Todt et al.,
1999). Another possibility could be that gentamicin requires
access to the intracellular medium to block GJCs, however,
we also performed experiments using gentamicin intracellularly
through the microinjection pipette and we do not see signif-
icant changes in the dye coupling. Generally, an increase in
gap junctional communication is associated with coordination
of physiological responses (Ren et al., 1994; Mears et al., 1995;
Curti and Pereda, 2004; Orellana et al., 2010; Johansen et al.,
2011; Mhaske et al., 2013). In the present study, we did not
ﬁnd a statistical difference in the dye coupling index in pres-
ence of gentamicin in HeLa cells expressing rCx26 or Cx43.
Therefore, we conclude that gentamicin applied extra or intra-
cellularly does not change the dye coupling in HeLa transfected
cells.
Recent studies have demonstrated that 24 h exposure to gen-
tamicin 418, an antibiotic structurally and functionally similar
to gentamicin, increases Cx43 phosphorylation and gap junction
coupling in tubular proximal epithelial cell lines but decreases cell
viability (Yao et al., 2010). Moreover, gain in HC activity has been
associated with an increased incidence in cell death (Contreras
et al., 2002; Orellana et al., 2010). Therefore, the gentamicin-
induced closure might be linked to a deﬁcient autocrine/paracrine
signaling as discussed above, rather than the direct consequence
of HC closure. Although gentamicin inhibits HCs and not GJCs,
its use as HC blocker should be taken cautiously because of its
pleiotropic effect on other membrane channels and its effect on
free radical generation as discussed above.
Altogether, the data presented in this work suggest a new phar-
macological target that could explain the deleterious side effects
of gentamicin in the inner ear.
CONCLUSION
In the present article, we report that extracellular gentamicin
inhibits the activity of Cx26 HCs expressed in HeLa cells and
Xenopus oocytes in a concentration-dependent manner without
affecting the intercellular coupling through Cx26 GJCs. This effect
does not exclusively require the C-terminus of Cx26 because it is
also observed in HCs with other Cxs composition presenting a
much longer C-terminal than Cx26. Finally and as described for
other HC blockers, gentamicin reduced the ATP-induced Ca2+
signals.
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